{"nct_id": "NCT05414448", "age": "Adults", "cancer_center_accrual_goal_upper": 0, "data_table4": "Interventional", "drug_list": {"drug": [{"drug_name": "Device: ENDOCUFF"}]}, "long_title": "Combination of Artificial Intelligence (ENDOAID) and Mucosal Exposure Device (ENDOCUFF) to Enhance Colorectal Neoplasia Detection: a Randomized Controlled Trial", "management_group_list": {"management_group": [{"is_primary": "Y", "management_group_name": "Group1"}]}, "oncology_group_list": {"oncology_group": [{"group_name": "Group1", "is_primary": "N"}]}, "phase": "NA", "principal_investigator": "", "principal_investigator_institution": "Chinese University of Hong Kong", "program_area_list": {"program_area": [{"is_primary": "Y", "program_area_name": "Program1"}]}, "protocol_id": 0, "protocol_no": "", "protocol_target_accrual": 1726, "protocol_type": "INTERVENTIONAL", "prior_treatment_requirements": ["Inclusion Criteria:", "1. Aged 45-85 years old;", "2. They require elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms such as anemia or altered bowel habit;", "3. Written informed consent obtained.", "Exclude - Exclusion Criteria:", "Exclude - 1. Contraindication to colonoscopy (e.g. intestinal obstruction or perforation)", "Exclude - 2. Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, uninterrupted anticoagulation or dual antiplatelets)", "Exclude - 3. Staged procedure for polypectomy or biopsy of known unresected lesions", "Exclude - 4. Previous surgical resection of colon", "Exclude - 5. Personal history of colorectal cancer", "Exclude - 6. Personal history of familial polyposis syndrome", "Exclude - 7. Personal history of inflammatory bowel disease", "Exclude - 8. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)", "Exclude - 9. Pregnancy", "Exclude - 10. Unable to obtain informed consent"], "short_title": "Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection", "site_list": {"site": []}, "sponsor_list": {"sponsor": [{"is_principal_sponsor": "Y", "sponsor_name": "Chinese University of Hong Kong", "sponsor_protocol_no": "", "sponsor_roles": "sponsor"}]}, "staff_list": {"protocol_staff": []}, "status": "open to accrual", "summary": "The investigators hypothesize that the combined use of CADe system (ENDOAID) and mucosal exposure device (Endocuff Vision\u00ae) would improve the adenoma detection rate when compared to CADe system alone.", "treatment_list": {"step": [{"arm": [{"arm_code": "ENDOAID", "arm_internal_id": 0, "arm_description": "CADe system will be used during withdrawal phase of colonoscopy.", "arm_suspended": "N", "dose_level": []}, {"arm_code": "ENDOAID with ENDOCUFF", "arm_internal_id": 1, "arm_description": "CADe system and mucosal exposure device (ENDOCUFF) will be used during withdrawal phase of colonoscopy.", "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Device: ENDOCUFF", "level_internal_id": 0, "level_suspended": "N"}]}], "match": [{"and": [{"clinical": {"oncotree_primary_diagnosis": "", "disease_status": ["", ""]}}, {"genomic": {"hugo_symbol": "", "variant_category": ""}}]}]}]}}